nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP3A4—prostate cancer	0.171	1	CbGaD
Rimonabant—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0428	0.0838	CbGbCtD
Rimonabant—CYP2C9—Nilutamide—prostate cancer	0.0387	0.0757	CbGbCtD
Rimonabant—CYP2C9—Bicalutamide—prostate cancer	0.0387	0.0757	CbGbCtD
Rimonabant—CYP1A2—Flutamide—prostate cancer	0.0356	0.0696	CbGbCtD
Rimonabant—CYP2D6—Bicalutamide—prostate cancer	0.0354	0.0692	CbGbCtD
Rimonabant—CYP2D6—Abiraterone—prostate cancer	0.0293	0.0573	CbGbCtD
Rimonabant—CYP1A2—Estrone—prostate cancer	0.0257	0.0503	CbGbCtD
Rimonabant—CYP2C9—Estrone—prostate cancer	0.0232	0.0453	CbGbCtD
Rimonabant—CYP3A4—Bicalutamide—prostate cancer	0.0225	0.044	CbGbCtD
Rimonabant—CYP3A4—Estramustine—prostate cancer	0.0209	0.0409	CbGbCtD
Rimonabant—CYP3A4—Flutamide—prostate cancer	0.0186	0.0365	CbGbCtD
Rimonabant—CYP3A4—Abiraterone—prostate cancer	0.0186	0.0365	CbGbCtD
Rimonabant—CYP2C9—Capecitabine—prostate cancer	0.0176	0.0344	CbGbCtD
Rimonabant—CYP1A2—Conjugated Estrogens—prostate cancer	0.0168	0.0329	CbGbCtD
Rimonabant—CYP1A2—Estradiol—prostate cancer	0.0148	0.0289	CbGbCtD
Rimonabant—CYP3A4—Cabazitaxel—prostate cancer	0.0138	0.027	CbGbCtD
Rimonabant—CYP3A4—Estrone—prostate cancer	0.0135	0.0264	CbGbCtD
Rimonabant—CYP2C9—Estradiol—prostate cancer	0.0133	0.026	CbGbCtD
Rimonabant—CYP3A4—Ethinyl Estradiol—prostate cancer	0.012	0.0235	CbGbCtD
Rimonabant—CYP1A2—Etoposide—prostate cancer	0.00964	0.0189	CbGbCtD
Rimonabant—CYP3A4—Conjugated Estrogens—prostate cancer	0.00881	0.0172	CbGbCtD
Rimonabant—CYP3A4—Mitoxantrone—prostate cancer	0.00801	0.0157	CbGbCtD
Rimonabant—CYP3A4—Estradiol—prostate cancer	0.00774	0.0151	CbGbCtD
Rimonabant—CYP3A4—Prednisone—prostate cancer	0.00665	0.013	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—prostate cancer	0.00542	0.0106	CbGbCtD
Rimonabant—CYP3A4—Etoposide—prostate cancer	0.00505	0.00988	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—prostate cancer	0.00462	0.00904	CbGbCtD
Rimonabant—CNR1—prostate gland—prostate cancer	0.00396	0.245	CbGeAlD
Rimonabant—CYP3A4—Doxorubicin—prostate cancer	0.00345	0.00674	CbGbCtD
Rimonabant—CYP1A2—urine—prostate cancer	0.00226	0.139	CbGeAlD
Rimonabant—CYP2C9—urine—prostate cancer	0.00214	0.132	CbGeAlD
Rimonabant—CNR1—testis—prostate cancer	0.00175	0.108	CbGeAlD
Rimonabant—CYP3A4—urine—prostate cancer	0.00163	0.101	CbGeAlD
Rimonabant—CYP2D6—urine—prostate cancer	0.00161	0.0991	CbGeAlD
Rimonabant—CNR1—lymph node—prostate cancer	0.00127	0.0781	CbGeAlD
Rimonabant—CYP1A2—renal system—prostate cancer	0.000552	0.034	CbGeAlD
Rimonabant—CYP3A4—renal system—prostate cancer	0.000399	0.0246	CbGeAlD
Rimonabant—CYP2D6—renal system—prostate cancer	0.000393	0.0242	CbGeAlD
Rimonabant—CYP2D6—testis—prostate cancer	0.000254	0.0157	CbGeAlD
Rimonabant—Infection—Mitoxantrone—prostate cancer	0.000139	0.000763	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—prostate cancer	0.000137	0.000753	CcSEcCtD
Rimonabant—Nausea—Ethinyl Estradiol—prostate cancer	0.000137	0.000751	CcSEcCtD
Rimonabant—Hypoglycaemia—Epirubicin—prostate cancer	0.000136	0.000747	CcSEcCtD
Rimonabant—Asthenia—Goserelin—prostate cancer	0.000136	0.000746	CcSEcCtD
Rimonabant—Skin disorder—Mitoxantrone—prostate cancer	0.000136	0.000746	CcSEcCtD
Rimonabant—Insomnia—Estradiol—prostate cancer	0.000136	0.000746	CcSEcCtD
Rimonabant—Hypoaesthesia—Docetaxel—prostate cancer	0.000136	0.000744	CcSEcCtD
Rimonabant—Lethargy—Epirubicin—prostate cancer	0.000136	0.000744	CcSEcCtD
Rimonabant—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000135	0.000743	CcSEcCtD
Rimonabant—Paraesthesia—Estradiol—prostate cancer	0.000135	0.00074	CcSEcCtD
Rimonabant—Asthenia—Conjugated Estrogens—prostate cancer	0.000135	0.000739	CcSEcCtD
Rimonabant—Pruritus—Goserelin—prostate cancer	0.000134	0.000736	CcSEcCtD
Rimonabant—Connective tissue disorder—Docetaxel—prostate cancer	0.000134	0.000734	CcSEcCtD
Rimonabant—Anorexia—Mitoxantrone—prostate cancer	0.000134	0.000732	CcSEcCtD
Rimonabant—Pruritus—Conjugated Estrogens—prostate cancer	0.000133	0.000729	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—prostate cancer	0.000131	0.000721	CcSEcCtD
Rimonabant—Hypoaesthesia—Capecitabine—prostate cancer	0.000131	0.00072	CcSEcCtD
Rimonabant—Decreased appetite—Estradiol—prostate cancer	0.000131	0.000717	CcSEcCtD
Rimonabant—Depression—Prednisone—prostate cancer	0.000131	0.000716	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—prostate cancer	0.00013	0.000715	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Estradiol—prostate cancer	0.00013	0.000712	CcSEcCtD
Rimonabant—Diarrhoea—Goserelin—prostate cancer	0.00013	0.000712	CcSEcCtD
Rimonabant—Connective tissue disorder—Capecitabine—prostate cancer	0.00013	0.000711	CcSEcCtD
Rimonabant—Fatigue—Estradiol—prostate cancer	0.00013	0.000711	CcSEcCtD
Rimonabant—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000129	0.000705	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—prostate cancer	0.000126	0.000691	CcSEcCtD
Rimonabant—Mood swings—Epirubicin—prostate cancer	0.000126	0.00069	CcSEcCtD
Rimonabant—Paraesthesia—Mitoxantrone—prostate cancer	0.000126	0.00069	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—prostate cancer	0.000126	0.000688	CcSEcCtD
Rimonabant—Dizziness—Goserelin—prostate cancer	0.000125	0.000688	CcSEcCtD
Rimonabant—Dizziness—Conjugated Estrogens—prostate cancer	0.000124	0.000681	CcSEcCtD
Rimonabant—Convulsion—Etoposide—prostate cancer	0.000124	0.000678	CcSEcCtD
Rimonabant—Angiopathy—Docetaxel—prostate cancer	0.000124	0.000678	CcSEcCtD
Rimonabant—Gastrointestinal pain—Estradiol—prostate cancer	0.000123	0.000674	CcSEcCtD
Rimonabant—Mediastinal disorder—Docetaxel—prostate cancer	0.000123	0.000674	CcSEcCtD
Rimonabant—Decreased appetite—Mitoxantrone—prostate cancer	0.000122	0.000668	CcSEcCtD
Rimonabant—Fatigue—Mitoxantrone—prostate cancer	0.000121	0.000662	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000121	0.000662	CcSEcCtD
Rimonabant—Vomiting—Goserelin—prostate cancer	0.000121	0.000661	CcSEcCtD
Rimonabant—Angiopathy—Capecitabine—prostate cancer	0.00012	0.000657	CcSEcCtD
Rimonabant—Rash—Goserelin—prostate cancer	0.00012	0.000656	CcSEcCtD
Rimonabant—Dermatitis—Goserelin—prostate cancer	0.00012	0.000655	CcSEcCtD
Rimonabant—Vomiting—Conjugated Estrogens—prostate cancer	0.000119	0.000655	CcSEcCtD
Rimonabant—Mental disorder—Docetaxel—prostate cancer	0.000119	0.000655	CcSEcCtD
Rimonabant—Mediastinal disorder—Capecitabine—prostate cancer	0.000119	0.000652	CcSEcCtD
Rimonabant—Abdominal pain—Estradiol—prostate cancer	0.000119	0.000652	CcSEcCtD
Rimonabant—Headache—Goserelin—prostate cancer	0.000119	0.000651	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—prostate cancer	0.000119	0.000651	CcSEcCtD
Rimonabant—Rash—Conjugated Estrogens—prostate cancer	0.000118	0.000649	CcSEcCtD
Rimonabant—Dermatitis—Conjugated Estrogens—prostate cancer	0.000118	0.000649	CcSEcCtD
Rimonabant—Headache—Conjugated Estrogens—prostate cancer	0.000118	0.000645	CcSEcCtD
Rimonabant—Hallucination—Prednisone—prostate cancer	0.000117	0.000641	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—prostate cancer	0.000117	0.000639	CcSEcCtD
Rimonabant—Infection—Etoposide—prostate cancer	0.000116	0.000635	CcSEcCtD
Rimonabant—Mental disorder—Capecitabine—prostate cancer	0.000116	0.000634	CcSEcCtD
Rimonabant—Connective tissue disorder—Prednisone—prostate cancer	0.000116	0.000633	CcSEcCtD
Rimonabant—Malnutrition—Capecitabine—prostate cancer	0.000115	0.00063	CcSEcCtD
Rimonabant—Influenza—Epirubicin—prostate cancer	0.000115	0.00063	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000115	0.000628	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—prostate cancer	0.000114	0.000626	CcSEcCtD
Rimonabant—Skin disorder—Etoposide—prostate cancer	0.000113	0.000621	CcSEcCtD
Rimonabant—Nausea—Goserelin—prostate cancer	0.000113	0.000618	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—prostate cancer	0.000113	0.000618	CcSEcCtD
Rimonabant—Nausea—Conjugated Estrogens—prostate cancer	0.000112	0.000612	CcSEcCtD
Rimonabant—Anorexia—Etoposide—prostate cancer	0.000111	0.000609	CcSEcCtD
Rimonabant—Abdominal pain—Mitoxantrone—prostate cancer	0.000111	0.000607	CcSEcCtD
Rimonabant—Muscle spasms—Capecitabine—prostate cancer	0.00011	0.000606	CcSEcCtD
Rimonabant—Asthenia—Estradiol—prostate cancer	0.000108	0.000591	CcSEcCtD
Rimonabant—Tremor—Capecitabine—prostate cancer	0.000108	0.00059	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000107	0.000585	CcSEcCtD
Rimonabant—Angiopathy—Prednisone—prostate cancer	0.000107	0.000585	CcSEcCtD
Rimonabant—Pruritus—Estradiol—prostate cancer	0.000106	0.000583	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—prostate cancer	0.000106	0.000583	CcSEcCtD
Rimonabant—Paraesthesia—Etoposide—prostate cancer	0.000105	0.000574	CcSEcCtD
Rimonabant—Mental disorder—Prednisone—prostate cancer	0.000103	0.000565	CcSEcCtD
Rimonabant—Diarrhoea—Estradiol—prostate cancer	0.000103	0.000564	CcSEcCtD
Rimonabant—Convulsion—Docetaxel—prostate cancer	0.000103	0.000564	CcSEcCtD
Rimonabant—Infestation—Epirubicin—prostate cancer	0.000102	0.000562	CcSEcCtD
Rimonabant—Infestation NOS—Epirubicin—prostate cancer	0.000102	0.000562	CcSEcCtD
Rimonabant—Malnutrition—Prednisone—prostate cancer	0.000102	0.000561	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—prostate cancer	0.000101	0.000555	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—prostate cancer	0.000101	0.000552	CcSEcCtD
Rimonabant—Asthenia—Mitoxantrone—prostate cancer	0.000101	0.000551	CcSEcCtD
Rimonabant—Fatigue—Etoposide—prostate cancer	0.0001	0.000551	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.0001	0.00055	CcSEcCtD
Rimonabant—Dizziness—Estradiol—prostate cancer	9.94e-05	0.000545	CcSEcCtD
Rimonabant—Dry mouth—Docetaxel—prostate cancer	9.88e-05	0.000542	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.88e-05	0.000542	CcSEcCtD
Rimonabant—Anxiety—Capecitabine—prostate cancer	9.75e-05	0.000534	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.72e-05	0.000533	CcSEcCtD
Rimonabant—Infection—Docetaxel—prostate cancer	9.62e-05	0.000528	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—prostate cancer	9.61e-05	0.000527	CcSEcCtD
Rimonabant—Diarrhoea—Mitoxantrone—prostate cancer	9.59e-05	0.000526	CcSEcCtD
Rimonabant—Dry mouth—Capecitabine—prostate cancer	9.57e-05	0.000524	CcSEcCtD
Rimonabant—Vomiting—Estradiol—prostate cancer	9.56e-05	0.000524	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—prostate cancer	9.53e-05	0.000522	CcSEcCtD
Rimonabant—Nervous system disorder—Docetaxel—prostate cancer	9.5e-05	0.000521	CcSEcCtD
Rimonabant—Rash—Estradiol—prostate cancer	9.48e-05	0.00052	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—prostate cancer	9.48e-05	0.00052	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—prostate cancer	9.48e-05	0.00052	CcSEcCtD
Rimonabant—Dermatitis—Estradiol—prostate cancer	9.47e-05	0.000519	CcSEcCtD
Rimonabant—Headache—Estradiol—prostate cancer	9.42e-05	0.000516	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—prostate cancer	9.41e-05	0.000516	CcSEcCtD
Rimonabant—Infection—Capecitabine—prostate cancer	9.32e-05	0.000511	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—prostate cancer	9.23e-05	0.000506	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—prostate cancer	9.21e-05	0.000505	CcSEcCtD
Rimonabant—Nervous system disorder—Capecitabine—prostate cancer	9.2e-05	0.000504	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—prostate cancer	9.15e-05	0.000502	CcSEcCtD
Rimonabant—Skin disorder—Capecitabine—prostate cancer	9.11e-05	0.000499	CcSEcCtD
Rimonabant—Hyperhidrosis—Capecitabine—prostate cancer	9.07e-05	0.000497	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—prostate cancer	9.04e-05	0.000495	CcSEcCtD
Rimonabant—Anorexia—Capecitabine—prostate cancer	8.94e-05	0.00049	CcSEcCtD
Rimonabant—Nausea—Estradiol—prostate cancer	8.93e-05	0.00049	CcSEcCtD
Rimonabant—Vomiting—Mitoxantrone—prostate cancer	8.91e-05	0.000488	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—prostate cancer	8.89e-05	0.000487	CcSEcCtD
Rimonabant—Convulsion—Prednisone—prostate cancer	8.87e-05	0.000486	CcSEcCtD
Rimonabant—Rash—Mitoxantrone—prostate cancer	8.84e-05	0.000484	CcSEcCtD
Rimonabant—Dermatitis—Mitoxantrone—prostate cancer	8.83e-05	0.000484	CcSEcCtD
Rimonabant—Headache—Mitoxantrone—prostate cancer	8.78e-05	0.000481	CcSEcCtD
Rimonabant—Insomnia—Docetaxel—prostate cancer	8.76e-05	0.00048	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—prostate cancer	8.7e-05	0.000477	CcSEcCtD
Rimonabant—Anxiety—Prednisone—prostate cancer	8.68e-05	0.000476	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.65e-05	0.000474	CcSEcCtD
Rimonabant—Insomnia—Capecitabine—prostate cancer	8.48e-05	0.000465	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—prostate cancer	8.47e-05	0.000464	CcSEcCtD
Rimonabant—Paraesthesia—Capecitabine—prostate cancer	8.42e-05	0.000462	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—prostate cancer	8.42e-05	0.000462	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Docetaxel—prostate cancer	8.36e-05	0.000458	CcSEcCtD
Rimonabant—Asthenia—Etoposide—prostate cancer	8.36e-05	0.000458	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—prostate cancer	8.36e-05	0.000458	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—prostate cancer	8.35e-05	0.000458	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—prostate cancer	8.34e-05	0.000457	CcSEcCtD
Rimonabant—Nausea—Mitoxantrone—prostate cancer	8.32e-05	0.000456	CcSEcCtD
Rimonabant—Infection—Prednisone—prostate cancer	8.3e-05	0.000455	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—prostate cancer	8.29e-05	0.000454	CcSEcCtD
Rimonabant—Pruritus—Etoposide—prostate cancer	8.25e-05	0.000452	CcSEcCtD
Rimonabant—Nervous system disorder—Prednisone—prostate cancer	8.19e-05	0.000449	CcSEcCtD
Rimonabant—Decreased appetite—Capecitabine—prostate cancer	8.15e-05	0.000447	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—prostate cancer	8.11e-05	0.000445	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Capecitabine—prostate cancer	8.1e-05	0.000444	CcSEcCtD
Rimonabant—Fatigue—Capecitabine—prostate cancer	8.09e-05	0.000443	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisone—prostate cancer	8.08e-05	0.000443	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—prostate cancer	8.06e-05	0.000442	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—prostate cancer	8.01e-05	0.000439	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—prostate cancer	7.97e-05	0.000437	CcSEcCtD
Rimonabant—Anorexia—Prednisone—prostate cancer	7.96e-05	0.000437	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—prostate cancer	7.92e-05	0.000434	CcSEcCtD
Rimonabant—Tension—Epirubicin—prostate cancer	7.86e-05	0.000431	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—prostate cancer	7.78e-05	0.000426	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—prostate cancer	7.72e-05	0.000423	CcSEcCtD
Rimonabant—Dizziness—Etoposide—prostate cancer	7.71e-05	0.000423	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—prostate cancer	7.7e-05	0.000422	CcSEcCtD
Rimonabant—Gastrointestinal pain—Capecitabine—prostate cancer	7.67e-05	0.00042	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—prostate cancer	7.67e-05	0.00042	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—prostate cancer	7.66e-05	0.00042	CcSEcCtD
Rimonabant—Insomnia—Prednisone—prostate cancer	7.56e-05	0.000414	CcSEcCtD
Rimonabant—Paraesthesia—Prednisone—prostate cancer	7.5e-05	0.000411	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—prostate cancer	7.45e-05	0.000409	CcSEcCtD
Rimonabant—Abdominal pain—Capecitabine—prostate cancer	7.41e-05	0.000406	CcSEcCtD
Rimonabant—Vomiting—Etoposide—prostate cancer	7.41e-05	0.000406	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—prostate cancer	7.41e-05	0.000406	CcSEcCtD
Rimonabant—Rash—Etoposide—prostate cancer	7.35e-05	0.000403	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—prostate cancer	7.34e-05	0.000402	CcSEcCtD
Rimonabant—Headache—Etoposide—prostate cancer	7.3e-05	0.0004	CcSEcCtD
Rimonabant—Tension—Doxorubicin—prostate cancer	7.27e-05	0.000398	CcSEcCtD
Rimonabant—Decreased appetite—Prednisone—prostate cancer	7.26e-05	0.000398	CcSEcCtD
Rimonabant—Fatigue—Prednisone—prostate cancer	7.2e-05	0.000395	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—prostate cancer	7.19e-05	0.000394	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—prostate cancer	7.12e-05	0.00039	CcSEcCtD
Rimonabant—Asthenia—Docetaxel—prostate cancer	6.95e-05	0.000381	CcSEcCtD
Rimonabant—Convulsion—Epirubicin—prostate cancer	6.94e-05	0.00038	CcSEcCtD
Rimonabant—Nausea—Etoposide—prostate cancer	6.92e-05	0.00038	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—prostate cancer	6.85e-05	0.000376	CcSEcCtD
Rimonabant—Gastrointestinal pain—Prednisone—prostate cancer	6.83e-05	0.000374	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—prostate cancer	6.79e-05	0.000372	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.77e-05	0.000371	CcSEcCtD
Rimonabant—Asthenia—Capecitabine—prostate cancer	6.73e-05	0.000369	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—prostate cancer	6.67e-05	0.000365	CcSEcCtD
Rimonabant—Pruritus—Capecitabine—prostate cancer	6.64e-05	0.000364	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—prostate cancer	6.63e-05	0.000363	CcSEcCtD
Rimonabant—Abdominal pain—Prednisone—prostate cancer	6.6e-05	0.000362	CcSEcCtD
Rimonabant—Infection—Epirubicin—prostate cancer	6.49e-05	0.000356	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—prostate cancer	6.42e-05	0.000352	CcSEcCtD
Rimonabant—Diarrhoea—Capecitabine—prostate cancer	6.42e-05	0.000352	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—prostate cancer	6.41e-05	0.000351	CcSEcCtD
Rimonabant—Dizziness—Docetaxel—prostate cancer	6.41e-05	0.000351	CcSEcCtD
Rimonabant—Skin disorder—Epirubicin—prostate cancer	6.35e-05	0.000348	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—prostate cancer	6.32e-05	0.000346	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—prostate cancer	6.28e-05	0.000344	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.26e-05	0.000343	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—prostate cancer	6.23e-05	0.000341	CcSEcCtD
Rimonabant—Dizziness—Capecitabine—prostate cancer	6.2e-05	0.00034	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—prostate cancer	6.17e-05	0.000338	CcSEcCtD
Rimonabant—Vomiting—Docetaxel—prostate cancer	6.16e-05	0.000338	CcSEcCtD
Rimonabant—Rash—Docetaxel—prostate cancer	6.11e-05	0.000335	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—prostate cancer	6.1e-05	0.000334	CcSEcCtD
Rimonabant—Headache—Docetaxel—prostate cancer	6.07e-05	0.000333	CcSEcCtD
Rimonabant—Infection—Doxorubicin—prostate cancer	6.01e-05	0.000329	CcSEcCtD
Rimonabant—Asthenia—Prednisone—prostate cancer	5.99e-05	0.000329	CcSEcCtD
Rimonabant—Vomiting—Capecitabine—prostate cancer	5.96e-05	0.000327	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—prostate cancer	5.93e-05	0.000325	CcSEcCtD
Rimonabant—Rash—Capecitabine—prostate cancer	5.91e-05	0.000324	CcSEcCtD
Rimonabant—Pruritus—Prednisone—prostate cancer	5.91e-05	0.000324	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—prostate cancer	5.91e-05	0.000324	CcSEcCtD
Rimonabant—Dermatitis—Capecitabine—prostate cancer	5.91e-05	0.000324	CcSEcCtD
Rimonabant—Headache—Capecitabine—prostate cancer	5.88e-05	0.000322	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—prostate cancer	5.87e-05	0.000322	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—prostate cancer	5.87e-05	0.000322	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—prostate cancer	5.84e-05	0.00032	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—prostate cancer	5.76e-05	0.000316	CcSEcCtD
Rimonabant—Nausea—Docetaxel—prostate cancer	5.75e-05	0.000315	CcSEcCtD
Rimonabant—Diarrhoea—Prednisone—prostate cancer	5.72e-05	0.000313	CcSEcCtD
Rimonabant—Decreased appetite—Epirubicin—prostate cancer	5.68e-05	0.000311	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—prostate cancer	5.64e-05	0.000309	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—prostate cancer	5.63e-05	0.000309	CcSEcCtD
Rimonabant—Nausea—Capecitabine—prostate cancer	5.57e-05	0.000305	CcSEcCtD
Rimonabant—Dizziness—Prednisone—prostate cancer	5.52e-05	0.000303	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—prostate cancer	5.47e-05	0.0003	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—prostate cancer	5.43e-05	0.000298	CcSEcCtD
Rimonabant—Gastrointestinal pain—Epirubicin—prostate cancer	5.34e-05	0.000293	CcSEcCtD
Rimonabant—Vomiting—Prednisone—prostate cancer	5.31e-05	0.000291	CcSEcCtD
Rimonabant—Rash—Prednisone—prostate cancer	5.27e-05	0.000289	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—prostate cancer	5.26e-05	0.000288	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—prostate cancer	5.26e-05	0.000288	CcSEcCtD
Rimonabant—Headache—Prednisone—prostate cancer	5.23e-05	0.000287	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.22e-05	0.000286	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—prostate cancer	5.21e-05	0.000286	CcSEcCtD
Rimonabant—Abdominal pain—Epirubicin—prostate cancer	5.16e-05	0.000283	CcSEcCtD
Rimonabant—Nausea—Prednisone—prostate cancer	4.96e-05	0.000272	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—prostate cancer	4.94e-05	0.000271	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—prostate cancer	4.78e-05	0.000262	CcSEcCtD
Rimonabant—Asthenia—Epirubicin—prostate cancer	4.69e-05	0.000257	CcSEcCtD
Rimonabant—Pruritus—Epirubicin—prostate cancer	4.62e-05	0.000253	CcSEcCtD
Rimonabant—Diarrhoea—Epirubicin—prostate cancer	4.47e-05	0.000245	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—prostate cancer	4.34e-05	0.000238	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—prostate cancer	4.32e-05	0.000237	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—prostate cancer	4.28e-05	0.000234	CcSEcCtD
Rimonabant—Vomiting—Epirubicin—prostate cancer	4.15e-05	0.000228	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—prostate cancer	4.14e-05	0.000227	CcSEcCtD
Rimonabant—Rash—Epirubicin—prostate cancer	4.12e-05	0.000226	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—prostate cancer	4.12e-05	0.000226	CcSEcCtD
Rimonabant—Headache—Epirubicin—prostate cancer	4.09e-05	0.000224	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—prostate cancer	4e-05	0.000219	CcSEcCtD
Rimonabant—Nausea—Epirubicin—prostate cancer	3.88e-05	0.000213	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—prostate cancer	3.84e-05	0.000211	CcSEcCtD
Rimonabant—Rash—Doxorubicin—prostate cancer	3.81e-05	0.000209	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—prostate cancer	3.81e-05	0.000209	CcSEcCtD
Rimonabant—Headache—Doxorubicin—prostate cancer	3.79e-05	0.000208	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—prostate cancer	3.59e-05	0.000197	CcSEcCtD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.47e-06	6.24e-05	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—prostate cancer	7.41e-06	6.19e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.41e-06	6.18e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TBXAS1—prostate cancer	7.38e-06	6.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA4—prostate cancer	7.38e-06	6.16e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC22A1—prostate cancer	7.34e-06	6.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.32e-06	6.11e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.32e-06	6.11e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.26e-06	6.06e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.22e-06	6.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.21e-06	6.02e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA2—prostate cancer	7.19e-06	6e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SULT2A1—prostate cancer	7.16e-06	5.97e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—prostate cancer	7.12e-06	5.94e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCG5—prostate cancer	7.1e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SULT1A1—prostate cancer	7.1e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MED12—prostate cancer	7.1e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNG5—prostate cancer	7.05e-06	5.88e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MED12—prostate cancer	7.04e-06	5.88e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.99e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACSL4—prostate cancer	6.99e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNG5—prostate cancer	6.98e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA1—prostate cancer	6.94e-06	5.79e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—prostate cancer	6.88e-06	5.75e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTO1—prostate cancer	6.86e-06	5.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSD3B2—prostate cancer	6.86e-06	5.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NAT2—prostate cancer	6.86e-06	5.73e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA3—prostate cancer	6.79e-06	5.67e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA3—prostate cancer	6.73e-06	5.62e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UMPS—prostate cancer	6.7e-06	5.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ARG2—prostate cancer	6.7e-06	5.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PHGDH—prostate cancer	6.7e-06	5.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.61e-06	5.52e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.6e-06	5.51e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLCB2—prostate cancer	6.58e-06	5.49e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LRP2—prostate cancer	6.58e-06	5.49e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.58e-06	5.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LDHB—prostate cancer	6.57e-06	5.48e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HPGDS—prostate cancer	6.47e-06	5.41e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—P4HB—prostate cancer	6.45e-06	5.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.45e-06	5.38e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.43e-06	5.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HPGDS—prostate cancer	6.42e-06	5.36e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.38e-06	5.32e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—prostate cancer	6.3e-06	5.26e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACHE—prostate cancer	6.28e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—prostate cancer	6.28e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.27e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PDHA1—prostate cancer	6.23e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UCP3—prostate cancer	6.23e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA3—prostate cancer	6.23e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TCN2—prostate cancer	6.23e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACHE—prostate cancer	6.22e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—prostate cancer	6.22e-06	5.2e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.21e-06	5.18e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.2e-06	5.18e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2A6—prostate cancer	6.15e-06	5.14e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.13e-06	5.12e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SULT2A1—prostate cancer	6.11e-06	5.11e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKR1C3—prostate cancer	6.04e-06	5.04e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MED12—prostate cancer	6.02e-06	5.02e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PRKACB—prostate cancer	6.01e-06	5.01e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKR1C3—prostate cancer	5.99e-06	5e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNG5—prostate cancer	5.97e-06	4.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PRKACB—prostate cancer	5.95e-06	4.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.94e-06	4.96e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.94e-06	4.96e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.94e-06	4.96e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.89e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—prostate cancer	5.81e-06	4.85e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.81e-06	4.85e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA3—prostate cancer	5.75e-06	4.8e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.7e-06	4.75e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA4—prostate cancer	5.7e-06	4.75e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA2—prostate cancer	5.66e-06	4.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.65e-06	4.72e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA2—prostate cancer	5.61e-06	4.69e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA2—prostate cancer	5.55e-06	4.63e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HPGDS—prostate cancer	5.48e-06	4.58e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCG5—prostate cancer	5.48e-06	4.58e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.48e-06	4.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.45e-06	4.55e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.4e-06	4.51e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.36e-06	4.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA1—prostate cancer	5.35e-06	4.47e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—prostate cancer	5.32e-06	4.44e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACHE—prostate cancer	5.32e-06	4.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NAT2—prostate cancer	5.29e-06	4.42e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTO1—prostate cancer	5.29e-06	4.42e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.29e-06	4.42e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.28e-06	4.41e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.26e-06	4.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.24e-06	4.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.23e-06	4.37e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NQO1—prostate cancer	5.22e-06	4.36e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NQO1—prostate cancer	5.17e-06	4.32e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TH—prostate cancer	5.14e-06	4.29e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKR1C3—prostate cancer	5.12e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TH—prostate cancer	5.1e-06	4.26e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.09e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PRKACB—prostate cancer	5.09e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLCB2—prostate cancer	5.08e-06	4.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LRP2—prostate cancer	5.08e-06	4.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.08e-06	4.24e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.07e-06	4.23e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.05e-06	4.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP17A1—prostate cancer	5.04e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.02e-06	4.19e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1B1—prostate cancer	5e-06	4.18e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—P4HB—prostate cancer	4.98e-06	4.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.97e-06	4.15e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.96e-06	4.14e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GGT1—prostate cancer	4.85e-06	4.05e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.84e-06	4.04e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GGT1—prostate cancer	4.8e-06	4.01e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA2—prostate cancer	4.8e-06	4.01e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA1—prostate cancer	4.77e-06	3.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA1—prostate cancer	4.73e-06	3.95e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.72e-06	3.94e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.7e-06	3.93e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.66e-06	3.89e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MED12—prostate cancer	4.64e-06	3.88e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNG5—prostate cancer	4.61e-06	3.85e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.58e-06	3.82e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—RXRA—prostate cancer	4.54e-06	3.79e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—RXRA—prostate cancer	4.5e-06	3.76e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.47e-06	3.73e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA3—prostate cancer	4.44e-06	3.7e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NQO1—prostate cancer	4.42e-06	3.69e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.38e-06	3.65e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—COMT—prostate cancer	4.37e-06	3.65e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TH—prostate cancer	4.36e-06	3.64e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—prostate cancer	4.35e-06	3.63e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—COMT—prostate cancer	4.34e-06	3.62e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.33e-06	3.61e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—prostate cancer	4.31e-06	3.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.31e-06	3.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.29e-06	3.58e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ITPR1—prostate cancer	4.28e-06	3.58e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ITPR1—prostate cancer	4.25e-06	3.54e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.24e-06	3.54e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HPGDS—prostate cancer	4.23e-06	3.53e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.21e-06	3.51e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.17e-06	3.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—prostate cancer	4.11e-06	3.43e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACHE—prostate cancer	4.11e-06	3.43e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GGT1—prostate cancer	4.1e-06	3.43e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.06e-06	3.39e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMS—prostate cancer	4.05e-06	3.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA1—prostate cancer	4.04e-06	3.38e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMS—prostate cancer	4.01e-06	3.35e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—prostate cancer	4e-06	3.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.98e-06	3.33e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—prostate cancer	3.97e-06	3.31e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.95e-06	3.3e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PRKACB—prostate cancer	3.93e-06	3.28e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—LPL—prostate cancer	3.93e-06	3.28e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LPL—prostate cancer	3.89e-06	3.25e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.89e-06	3.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—RXRA—prostate cancer	3.85e-06	3.21e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.79e-06	3.17e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ERCC2—prostate cancer	3.76e-06	3.14e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.76e-06	3.14e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.74e-06	3.12e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ERCC2—prostate cancer	3.73e-06	3.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—COMT—prostate cancer	3.7e-06	3.09e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA2—prostate cancer	3.7e-06	3.09e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—prostate cancer	3.69e-06	3.08e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ITPR1—prostate cancer	3.63e-06	3.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.57e-06	2.98e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—prostate cancer	3.53e-06	2.95e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.53e-06	2.95e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—prostate cancer	3.5e-06	2.93e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARA—prostate cancer	3.47e-06	2.9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.45e-06	2.88e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARA—prostate cancer	3.44e-06	2.87e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMS—prostate cancer	3.43e-06	2.86e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NQO1—prostate cancer	3.41e-06	2.85e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—prostate cancer	3.39e-06	2.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TH—prostate cancer	3.36e-06	2.81e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LPL—prostate cancer	3.33e-06	2.78e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.27e-06	2.73e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAV1—prostate cancer	3.26e-06	2.72e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAV1—prostate cancer	3.23e-06	2.7e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.21e-06	2.68e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ERCC2—prostate cancer	3.19e-06	2.66e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GGT1—prostate cancer	3.17e-06	2.64e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA1—prostate cancer	3.12e-06	2.61e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.09e-06	2.58e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.08e-06	2.57e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—prostate cancer	2.99e-06	2.5e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.97e-06	2.48e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—RXRA—prostate cancer	2.97e-06	2.48e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.94e-06	2.46e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARA—prostate cancer	2.94e-06	2.45e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COMT—prostate cancer	2.86e-06	2.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—prostate cancer	2.85e-06	2.38e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—INS—prostate cancer	2.81e-06	2.35e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ITPR1—prostate cancer	2.8e-06	2.34e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—INS—prostate cancer	2.79e-06	2.33e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAV1—prostate cancer	2.76e-06	2.31e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CREBBP—prostate cancer	2.75e-06	2.3e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CREBBP—prostate cancer	2.73e-06	2.28e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMS—prostate cancer	2.65e-06	2.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.64e-06	2.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—prostate cancer	2.62e-06	2.18e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.61e-06	2.18e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.59e-06	2.16e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LPL—prostate cancer	2.57e-06	2.14e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.52e-06	2.1e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.48e-06	2.07e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—prostate cancer	2.47e-06	2.06e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ERCC2—prostate cancer	2.46e-06	2.05e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—prostate cancer	2.44e-06	2.04e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—INS—prostate cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CREBBP—prostate cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—prostate cancer	2.31e-06	1.93e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.28e-06	1.9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARA—prostate cancer	2.27e-06	1.89e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.26e-06	1.88e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—prostate cancer	2.25e-06	1.88e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—prostate cancer	2.24e-06	1.87e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.21e-06	1.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAV1—prostate cancer	2.13e-06	1.78e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—prostate cancer	2.09e-06	1.74e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—prostate cancer	1.97e-06	1.64e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—prostate cancer	1.95e-06	1.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.94e-06	1.62e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.93e-06	1.61e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—prostate cancer	1.91e-06	1.59e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—EP300—prostate cancer	1.88e-06	1.57e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—EP300—prostate cancer	1.86e-06	1.55e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—INS—prostate cancer	1.84e-06	1.53e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CREBBP—prostate cancer	1.8e-06	1.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.71e-06	1.43e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—prostate cancer	1.67e-06	1.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—prostate cancer	1.61e-06	1.35e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—EP300—prostate cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—prostate cancer	1.47e-06	1.23e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.16e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—prostate cancer	1.29e-06	1.07e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—EP300—prostate cancer	1.23e-06	1.02e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.18e-06	9.81e-06	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—prostate cancer	1.13e-06	9.46e-06	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—prostate cancer	1.12e-06	9.38e-06	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—prostate cancer	9.6e-07	8.02e-06	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.07e-07	7.57e-06	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—prostate cancer	7.41e-07	6.19e-06	CbGpPWpGaD
